Results 161 to 170 of about 255,046 (288)

Antibody Assay and Anti-Inflammatory Function Evaluation of Therapeutic Potential of Different Intravenous Immunoglobulins for Alzheimer's Disease. [PDF]

Int J Mol Sci, 2023
Fei Z, Pei R, Pan B, Ye S, Zhang R, Ma L, Wang Z, Li C, Du X, Cao H.   +9 more
europepmc   +1 more source

Are Intravenous Immunoglobulins Effective in Preventing Primary EBV Infection in Pediatric Kidney Transplant Recipients? [PDF]

Medicina (Kaunas)
Bertazza Partigiani N, Bertozzi V, Sangermano M, Benetti E.   +3 more
europepmc   +1 more source

Intravenous immunoglobulins in the management of acute chest syndrome in two Jehovah's Witnesses with sickle cell disease. [PDF]

Haematologica
Begali F, Ceolan J, Vitale S, Villaboni S, Merlo M, Zamperini R, Bertazzo R, Luz SR, Mazzi F, De Franceschi L.   +9 more
europepmc   +1 more source

Improvement in Primary Autoimmune Myelofibrosis Following a Short Course of Steroids and Intravenous Immunoglobulins. [PDF]

Cureus, 2022
Prakash S, Alhariri S, Hassan M, Patel PK, Patel PK, Corral J.   +5 more
europepmc   +1 more source

Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab. [PDF]

J Neurovirol, 2022
Boesl F, Allers K, Herm J, Scheider T, Franke C.   +4 more
europepmc   +1 more source

Improvement of plaquelike cutaneous mucinosis after intravenous immunoglobulins treatment

JAAD Case Reports, 2020
Jorge Magdaleno-Tapial, MD, Cristian Valenzuela-Oñate, MD, Álvaro Martínez-Doménech, MD, Marta García-Legaz-Martínez, MD, Juan José Tamarit-García, PhD, Violeta Zaragoza-Ninet, PhD, Víctor Alegre-de Miquel, PhD, Amparo Pérez-Ferriols, PhD   +7 more
doaj   +1 more source

Interleukin‐2 Deprived State of Regulatory T cells and Their Recovery by Low‐Dose Interleukin‐2 in Patients With Inflammatory Myopathies

Arthritis &Rheumatology, EarlyView.
Objective Regeneration and expansion of Treg by low‐dose interleukin‐2 (IL‐2) therapy is considered a potential treatment strategy for a wide range of autoimmune diseases. To provide a pathophysiologically‐based rationale for low‐dose IL‐2 therapy, we investigated whether reversible defects in the Treg–IL‐2 axis emerge in inflammatory myopathies ...
Justus Ohmes, Luisa R. Monne, Sara Comdühr, Fynn Gerlach, Hanna Grasshoff, Alexander Dübbers, Antje Müller, Alexander Scheffold, Gabriela Riemekasten, Reza Akbarzadeh, Jens Y. Humrich   +10 more
wiley   +1 more source

Osmotic Nephropathy Induced by L-Proline Stabilized Sucrose-free Intravenous Immunoglobulins: A Case Report. [PDF]

Kidney Med
Ulpiano Trillig A, Rotman S, Mehier P, Rossier A, Vogel G.   +4 more
europepmc   +1 more source

Treatment with IgM-enriched intravenous immunoglobulins enhances clearance of stroke-associated bacterial lung infection. [PDF]

Immunology, 2022
McCulloch L, Harris AJ, Malbon A, Daniels MJD, Younas M, Grainger JR, Allan SM, Smith CJ, McColl BW.   +8 more
europepmc   +1 more source

Intravenous immunoglobulins. [PDF]

BMJ, 1991
openaire   +2 more sources